| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On October 21, 2026, Akebia Therapeutics, Inc. (the “Company”) received a deficiency letter (the "Notice") from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the... |
| 14 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 7, 2026, Nicholas Grund, Senior Vice President and Chief Commercial Officer of Akebia Therapeutics, Inc. (the “Company”), notified the Company of his decision to resign his employment with the Company for personal reasons. His... |
| 10 Aug 2026 |
Form 4: Butler John P., Director
Received 350,000 shares by exercise or conversion ($221K) |
| 05 Aug 2026 | S-8 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 01 Jul 2026 |
Form 4: Ostrowski Erik, SVP, CFO, CBO & Treasurer
Sold 56,019 shares ($62.2K) |
| 30 Jun 2026 | 8-K: Regulation FD Disclosure; Other Events |
| 29 Jun 2026 | 144 |
| 22 Jun 2026 |
Form 4: Wolf Myles, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 |
Form 4: Smith Cynthia, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 |
Form 4: Frieson Ron, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 |
Form 4: Zumwalt Leanne M, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 |
Form 4: Adams Adrian, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 |
Form 4: Rogers Michael W, Director
Received 35,700 shares as a grant or award · Granted 53,600 Stock Option (Right to buy) |
| 22 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 12 May 2026 | SCHEDULE 13G |
| 07 May 2026 | 10-Q |
| 07 May 2026 | 8-K: Results of Operations and Financial Condition |
| 29 Apr 2026 | ARS |
Loading...
